GLP-1 Pills vs Injections: Which Weight Loss Treatment Is Right for You? (UK 2026)

If you've been looking into GLP-1 weight loss treatments, you've probably noticed the options have just got a lot more interesting. For years, if you wanted a clinically proven GLP-1 medication in the UK, a weekly injection was your only choice. That's changing in 2026. Oral GLP-1 tablets are arriving, and suddenly there's a real question worth asking: which format is actually right for you?

This isn't about which is "better" in some abstract sense. It's about what fits your life, your preferences, and your goals. Let's break it down properly.

First, what's actually available?

It's worth getting clear on what's out there, because the GLP-1 landscape in the UK has shifted significantly in 2026. Here's a quick rundown of the main options:

For a live comparison of prices across all UK providers right now, we pull together current rates from Numan, Voy, Medexpress, Juniper and more in one place.

How do they all actually work?

Whether you're injecting or swallowing a tablet, the underlying biology is the same. All GLP-1 medications mimic a natural gut hormone called glucagon-like peptide-1, which your body produces after eating. They suppress appetite, slow down digestion so you feel fuller for longer, and help regulate blood sugar levels.

• GLP-1 only: Wegovy injection, Wegovy pill, Foundayo - all activate the GLP-1 pathway to reduce appetite and slow gastric emptying
• GLP-1 + GIP dual agonist: Mounjaro (tirzepatide) targets two hormone pathways simultaneously - which is why it consistently produces the highest average weight loss in trials

The key practical difference between oral and injectable formats is bioavailability, how much of the drug actually reaches your bloodstream. Injections bypass the digestive system entirely, giving roughly 89% bioavailability. Oral semaglutide must survive the stomach and intestines first, which is why the pill dose (25mg) is so much higher than the injection dose (2.4mg). It's compensating for lower absorption.

NOTE ON RYBELSUS: You may have heard of Rybelsus, an existing oral semaglutide tablet already available in the UK. It's not the same as the Wegovy pill - it's approved only for type 2 diabetes and comes in a lower 14mg dose. The new Wegovy pill is 25mg and specifically approved for weight loss. Voy and Juniper both flag this distinction as important.

Side-by-side comparison: pills vs injections

Here's how the main UK GLP-1 options stack up across the factors that matter most. This table draws on data from Voy, Phlo Clinic, Numan, and Juniper.

Averages from clinical trials alongside diet and lifestyle support. Trials used different designs and cannot be directly compared. Individual results will vary. Sources: Voy, Phlo Clinic, Numan, Juniper, OASIS 4, STEP 1, SURMOUNT-1 trials.

Let's talk about efficacy - is the pill as good as the injection?

This is the question everyone asks first, and the honest answer is: pretty much, yes (at least for semaglutide). The OASIS 4 trial found that the Wegovy pill produced up to 16.6% average weight loss over 64 weeks in people who were fully adherent. That's remarkably close to the 15-17% seen with injectable Wegovy in the STEP 1 trial.

As Phlo Clinic noted after the FDA approval, the results from the clinical trials are very similar - the Wegovy injection showed slightly higher average weight loss (15% vs 14% in some trial read-outs), but overall the gap is very small. Voy echoes this, noting that the gap between oral and injectable semaglutide is narrowing significantly at the higher approved doses.

Where injections still pull ahead is with Mounjaro. Because tirzepatide activates both GLP-1 and GIP hormone pathways, it consistently delivers higher average weight loss (up to 22.5% in trials) than any semaglutide-based option, whether pill or injection. If maximum efficacy is your primary goal and you're comfortable with a weekly injection, Mounjaro remains the strongest option clinically.

Foundayo (orforglipron) is slightly behind the pack on weight loss figures, with trials showing 11-12.4% at the highest dose. But it has one unique advantage: unlike the Wegovy pill, it can be taken any time of day without food or water restrictions - potentially making it the most flexible option when it reaches the UK.

Compare all UK GLP-1 providers side by side at: healthcomparehub.vercel.app/weight-loss

Day-to-day ease of use - this matters more than people think

Efficacy figures from trials assume consistent use. And consistent use depends heavily on how easy a treatment is to fit into your actual life.

The case for injections

Once-weekly dosing is genuinely easy to stay on top of. You pick a day and that's it for the week. There's no daily routine to remember, no 30-minute fast to observe. You can eat and drink straight after.

The downside? Storage. Both Wegovy and Mounjaro pens need to be refrigerated, which creates friction when travelling. And of course, you need to be comfortable with needles!

The case for the pill

For the significant proportion of people who are needle-averse, Numan's own research found this is a major barrier preventing people from accessing GLP-1 treatment. The pill is a genuine game-changer. A daily tablet looks and feels like any other supplement. It's discreet, travels easily, requires no sharps bin, and nothing needs refrigerating.

The trade-off is the morning routine. The Wegovy pill must be taken first thing on an empty stomach with no more than 120ml of plain water, with a 30-minute wait before eating, drinking coffee, or taking other medication. As Dr Weightmans notes, this is the most important thing to get right with oral semaglutide.

Cost: what will you actually pay?

Wegovy injection currently costs around £86-£300 per month depending on dose and provider. Mounjaro typically runs £149-£299 per month privately. The Wegovy pill is expected to come in below current injection costs.

Prices vary a lot between providers, and many don't include consultation fees in their headline figures. The best way to get a true like-for-like comparison is here!

Side effects? Are pills or injections easier to tolerate?

Honestly, they're very similar. All GLP-1 medications can cause nausea, diarrhoea, constipation, and vomiting. Particularly when starting a new dose. These effects are generally mild to moderate and improve as your body adjusts. The gradual dose escalation used by all four options is specifically designed to minimise this.

One small difference: GI side effects with oral semaglutide may be slightly more common than with the injection, possibly because of the higher dose required to compensate for lower oral bioavailability. But the overall tolerability profiles are broadly comparable, a point reinforced by MedExpress in their GLP-1 overview.

Where to compare UK providers

One of the biggest frustrations when starting GLP-1 treatment is that prices, what's included, and clinical support vary significantly between providers. Some headline prices exclude consultations. Some include a full clinical programme with coaching and support, even those who give free supplements away to help with side effects.

The easiest way to cut through the noise is to use Health Compare Hub the most comprehensive independent comparison of UK GLP-1 providers, with up-to-date pricing, what's included, and links to get started with each.